
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
The logo of Gilead Sciences pharmaceutical company is seen in Oceanside, California, April 29, 2020. Mike Blake | Reuters The Food and Drug Administration on Wednesday approved Gilead's twice-yearly antiviral injection for preventing HIV – a milestone …